Hydroxygenkwanin is primarily studied for its biological activities, particularly in the field of pharmacology and natural product research. It exhibits strong antioxidant properties, helping to neutralize free radicals and reduce oxidative stress in cells. This makes it a candidate of interest for developing therapies related to aging, neurodegenerative diseases, and cardiovascular disorders. It has also shown anti-inflammatory effects by inhibiting key inflammatory pathways and reducing the production of pro-inflammatory cytokines. Due to this, it is being explored for use in treating chronic inflammatory conditions such as arthritis and inflammatory bowel disease. In cancer research, hydroxygenkwanin demonstrates potential anticancer activity by inducing apoptosis and inhibiting the proliferation of certain tumor cell lines, including those of breast, liver, and colon cancers. Its ability to interfere with cell cycle progression and modulate signaling pathways like NF-κB and MAPK contributes to its antitumor effects. Additionally, it may have applications in metabolic health, with some studies indicating it can help regulate glucose metabolism and improve insulin sensitivity, suggesting a role in managing type 2 diabetes. Overall, hydroxygenkwanin is a promising bioactive compound for use in nutraceuticals, functional foods, and pharmaceutical development, especially where natural compounds with multi-target effects are desired.